Results 191 to 200 of about 5,984,877 (353)
Some Single-Valued Neutrosophic Power Heronian Aggregation Operators and Their Application to Multiple-Attribute Group Decision-Making [PDF]
Shuping Zhao +4 more
openalex +1 more source
Einstein aggregation operators for multicriteria group decision making in uncertain environments using cubic picture fuzzy sets. [PDF]
Tanoli MNK +5 more
europepmc +1 more source
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon +9 more
wiley +1 more source
Influencing the physiology and decisions of groups: Physiological linkage during group decision-making [PDF]
Katherine R. Thorson +3 more
openalex +1 more source
A novel approach to group decision-making using generalized bipolar neutrosophic sets. [PDF]
Fahmi A, Khan A, Abdeljawad T.
europepmc +1 more source
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee +8 more
wiley +1 more source
Context-Aware Emotion-Based Model for Group Decision Making
Goreti Marreiros +3 more
openalex +2 more sources
An enhanced fuzzy credibility bidirectional projection based multi-attribute group decision making and its application in sports equipment supplier selection. [PDF]
Liu L.
europepmc +1 more source
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat +8 more
wiley +1 more source

